| # | Title | Journal | Year | Citations |
|---|
| 1 | Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy | Molecular Carcinogenesis | 1995 | 780 |
| 2 | Molecular mechanisms of Nrf2‐mediated antioxidant response | Molecular Carcinogenesis | 2009 | 666 |
| 3 | Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis | Molecular Carcinogenesis | 2011 | 494 |
| 4 | How many mutations are required for tumorigenesis? implications from human cancer data | Molecular Carcinogenesis | 1993 | 370 |
| 5 | Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis | Molecular Carcinogenesis | 1999 | 366 |
| 6 | Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules | Molecular Carcinogenesis | 2015 | 324 |
| 7 | Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of dna base damage | Molecular Carcinogenesis | 2006 | 319 |
| 8 | Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance | Molecular Carcinogenesis | 2013 | 306 |
| 9 | Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue | Molecular Carcinogenesis | 1999 | 303 |
| 10 | In vitro three‐dimensional (3D) models in cancer research: An update | Molecular Carcinogenesis | 2013 | 276 |
| 11 | FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation | Molecular Carcinogenesis | 2018 | 267 |
| 12 | NF-κB and cancer: Mechanisms and targets | Molecular Carcinogenesis | 2006 | 262 |
| 13 | A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer | Molecular Carcinogenesis | 2015 | 261 |
| 14 | Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas | Molecular Carcinogenesis | 1991 | 256 |
| 15 | Ras gene mutation and amplification in human nonmelanoma skin cancers | Molecular Carcinogenesis | 1991 | 250 |
| 16 | Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers | Molecular Carcinogenesis | 2008 | 249 |
| 17 | Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes | Molecular Carcinogenesis | 1998 | 245 |
| 18 | Effects of genetic background on tumorigenesis inp53-deficient mice | Molecular Carcinogenesis | 1995 | 243 |
| 19 | The functional contrariety of JNK | Molecular Carcinogenesis | 2007 | 239 |
| 20 | Cell-Cycle Arrest at G2/M and Growth Inhibition by Apigenin in Human Colon Carcinoma Cell Lines | Molecular Carcinogenesis | 2000 | 237 |
| 21 | Diabetes and pancreatic cancer | Molecular Carcinogenesis | 2012 | 229 |
| 22 | Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis | Molecular Carcinogenesis | 1994 | 227 |
| 23 | Polymorphic variation inhOGG1 and risk of cancer: A review of the functional and epidemiologic literature | Molecular Carcinogenesis | 2005 | 227 |
| 24 | Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) | Molecular Carcinogenesis | 2007 | 217 |
| 25 | Gene expression analysis of prostate cancers | Molecular Carcinogenesis | 2002 | 216 |
| 26 | Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer | Molecular Carcinogenesis | 2011 | 206 |
| 27 | Mutations of thep53 tumor suppressor gene in neoplasms of the human nervous system | Molecular Carcinogenesis | 1993 | 205 |
| 28 | Proprotein convertases: “Master switches” in the regulation of tumor growth and progression | Molecular Carcinogenesis | 2005 | 202 |
| 29 | Prostate cancer stem/progenitor cells: Identification, characterization, and implications | Molecular Carcinogenesis | 2007 | 201 |
| 30 | Upregulation of the long non‐coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis | Molecular Carcinogenesis | 2013 | 201 |
| 31 | Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis | Molecular Carcinogenesis | 2006 | 195 |
| 32 | Genetic susceptibility to pancreatic cancer | Molecular Carcinogenesis | 2012 | 192 |
| 33 | DNA methyltransferase and demethylase in human prostate cancer | Molecular Carcinogenesis | 2002 | 187 |
| 34 | An approach to proteomic analysis of human tumors | Molecular Carcinogenesis | 2000 | 186 |
| 35 | Multiple mechanisms are involved in 6‐gingerol‐induced cell growth arrest and apoptosis in human colorectal cancer cells | Molecular Carcinogenesis | 2008 | 181 |
| 36 | Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms | Molecular Carcinogenesis | 2012 | 179 |
| 37 | Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus | Molecular Carcinogenesis | 2003 | 174 |
| 38 | Activating point mutations of thegsp oncogene in human thyroid adenomas | Molecular Carcinogenesis | 1991 | 169 |
| 39 | A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth | Molecular Carcinogenesis | 2007 | 169 |
| 40 | JAK/STAT/SOCS‐signaling pathway and colon and rectal cancer | Molecular Carcinogenesis | 2013 | 169 |
| 41 | Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity | Molecular Carcinogenesis | 2006 | 168 |
| 42 | Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study | Molecular Carcinogenesis | 2012 | 167 |
| 43 | Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors | Molecular Carcinogenesis | 2006 | 165 |
| 44 | The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrenetrans-7, 8-dihydrodiol | Molecular Carcinogenesis | 1994 | 163 |
| 45 | Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells | Molecular Carcinogenesis | 2004 | 162 |
| 46 | Resveratrol directly targets COX‐2 to inhibit carcinogenesis | Molecular Carcinogenesis | 2008 | 162 |
| 47 | Pancreatic cancer: Overview of descriptive epidemiology | Molecular Carcinogenesis | 2012 | 162 |
| 48 | Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid | Molecular Carcinogenesis | 1996 | 161 |
| 49 | Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells | Molecular Carcinogenesis | 1994 | 160 |
| 50 | Co-regulation of B-Myb expression by E2F1 and EGF receptor | Molecular Carcinogenesis | 2006 | 157 |
